Same market data, $1.55 or $7,340 a month: what actually sets the price

A non-professional watching top-of-book prices from one CME Group exchange pays $1.55 a month for that screen. A firm at the top automated trading tier pays $7,340 a month for that same exchange. Both numbers sit on the same fee list, effective June 1, 2026.

Those two figures are not like for like. One is per device and the other is per licensee group, and they buy different rights. That is the point: in market data, you are mostly paying for how the data is used.

The industry bill keeps growing. Global spend on financial market data reached a record $49.2 billion in 2025, up 6.5%, according to Burton-Taylor research from TP ICAP. And CME's 2027 notice, dated August 10, says most of its futures and options data fees will rise by up to 3.5% on January 1.

The price follows the reader

All figures below are monthly and per exchange, from CME's June 2026 list.

Fees are assessed per exchange, and this list covers four: CME, CBOT, NYMEX and COMEX. Our arithmetic: a firm paying that top automated tier on all four would pay $29,360 a month, or about $352,000 a year, before any feed, screen or distribution fees.

Three details that move the bill

These points come from CME's non-display guidelines, updated January 2025. The reading of what they mean for a budget is ours.

Application count works in steps. For A1, one application costs $609. A second moves you to $1,820, roughly triple. A fourth moves you to $3,640. So one new system can cost far more than its share, and retiring one can drop a whole tier. CME notes that firms choosing the Enterprise tier skip per-application reporting, which is a real saving in effort, but it is worth checking against your actual count.

Delayed data is not an exit. CME treats data as delayed from 10 minutes to 8 hours after transmission, and delayed data used by software still counts toward the fee tiers. After 8 hours it becomes historical, which must be licensed but "carries no fees at this time" for non-display use. Some research and backtesting may be able to run on that, if the work allows it.

Categories stack. Licenses run concurrently, so a firm that trades automatically and also runs risk and research systems can hold Category A and Category C at once. There is one useful exception: a firm licensed only for semi-automated trading is charged the Basic fee, however many such systems it uses.

The AI agent question

CME defines an application as "a system or computer software that uses Information for Non-Display Use." That wording predates today's agent wave, but it is hard to read an agent that consumes a live feed as anything other than software using data.

This is the open question for anyone adding agents to a trading stack. If each one counts as an application, a small pilot could move a firm up a tier. We have not seen CME address agents by name, so ask them how your setup counts.

CME has addressed AI more broadly. Its advisory, updated February 2024, says training a model on its data "may require a Non-Display license." It also says a firm using a third party's AI tool is "equally responsible" for internal controls over access to CME data. And it warns that letting data into a network without an entitlement system makes every device on that network fee liable.

What to check before January

1. Application inventory. Does the list you report match what is running? Look for retired systems and for agents nobody has added.
2. Exchange coverage. Fees are per exchange. Is each one still used?
3. Data age. Which research jobs truly need data under 8 hours old?
4. Access controls. Can you show which applications, users and devices can reach each feed?
5. Distributor pricing. Retail example: CME lists its depth bundle at $36.50 for a non-professional, while AMP Futures lists a level 2 bundle at $45 and says its fees "may exceed the costs AMP pays." Distributors have real costs and AMP discloses this openly. The point is simply to compare your invoice with the source list.

Is this pricing fair?

That is contested. In November 2024, Healthy Markets petitioned the CFTC to review and disapprove CME's 2025 fee and license changes, arguing that some of the costs fall hardest on smaller participants. That is one group's argument in a petition, not a regulatory finding. CME is also not alone in charging more for software use: Nasdaq's Nordic and Baltic 2027 changes raise general fees by 3.3% and non-display fees by 5%.

Whatever your view, the practical lesson holds. A market data bill is a record of how your systems use data. Most firms can read that record more closely than they do, and agents make it worth reading now.

How many applications would your firm report today?

References

• CME Group Market Data Fee List, effective June 1, 2026
• CME Group Market Data Fee List, effective January 1, 2027
• CME Group 2027 Market Data Fee Notice, August 10, 2026
• CME Group Non-Display Use guidelines and FAQ, updated January 2025
• CME Group advisory on data in AI solutions, updated February 2024
• Mondo Visione: record growth across the market data landscape, reporting Burton-Taylor research from TP ICAP
• AMP Futures: exchange data fees, effective June 1, 2026
• Nasdaq Nordic and Baltic 2027 fee announcement
• Healthy Markets letter to the CFTC, November 19, 2024

Fees are CME Group's published list prices and exclude licensing options not shown there. Your bill depends on your license terms. The totals and interpretations are ours. This article is commentary, not licensing, legal or financial advice.